TRASTUZUMAB
trastuzumab 600 mg/5 mL injection, 5 mL vial
TRASTUZUMAB (10743K)
10743K
Manner of administration:Injection
Restriction 10212
Indication: Early HER2 positive breast cancer
Treatment phase: 3 weekly treatment regimen
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 3 | DPMQ: $1,470.22 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Herceptin SC | |||||